1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • de Cueto M, Aliaga L, Alós JI, Canut A, Los-Arcos I, Martínez JA, Mensa J, Pintado V, Rodriguez-Pardo D, Yuste JR, Pigrau C.

    Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 35(5): 314-320. Nº de citas: 46

    [doi:10.1016/j.eimc.2016.11.005]

  • Cordero E, Roca-Oporto C, Bulnes-Ramos A, Aydillo T, Gavaldà J, Moreno A, Torre-Cisneros J, Montejo JM, Fortun J, Muñoz P, Sabé N, Fariñas MC, Blanes-Julia M, López-Medrano F, Suárez-Benjumea A, Martinez-Atienza J, Rosso-Fernández C, Pérez-Romero P.

    Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1-2, a Randomized Controlled Clinical Trial.

    CLINICAL INFECTIOUS DISEASES . 64(7): 829-838. Nº de citas: 63

    [doi:10.1093/cid/ciw855]

  • Cabañero A, Dronda F, Saldaña D, Hermida JM, Muñoz G, Moreno S.

    Management of a tracheoesophageal fistula in a patient with AIDS.

    Asian cardiovascular & thoracic annals . 25(3): 226-228.

    [doi:10.1177/0218492317696374]

  • Ariza J, Cobo J, Baraia-Etxaburu J, de Benito N, Bori G, Cabo J, Corona P, Esteban J, Horcajada JP, Lora-Tamayo J, Murillo O, Palomino J, Parra J, Pigrau C, Del Pozo JL, Riera M, Rodríguez D, Sánchez-Somolinos M, Soriano A, Del Toro MD, de la Torre B, Microbiología Clínica (SEIMC) along with expert orthopedic surgeons from the Spa.

    Executive summary of management of prosthetic joint infections. Clinical practice guidelines by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 35(3): 189-195. Nº de citas: 48

    [doi:10.1016/j.eimc.2016.08.012]

  • Palacios-Baena ZR, Gutiérrez-Gutiérrez B, De Cueto M, Viale P, Venditti M, Hernández-Torres A, Oliver A, Martínez-Martínez L, Calbo E, Pintado V, Gasch O, Almirante B, Antonio Lepe J, Pitout J, Akova M, Peña-Miralles C, Schwaber MJ, Tumbarello M, Tacconelli E, Origüen J, Prim N, Bou G, Giamarellou H, Bermejo J, Hamprecht A, Pérez F, Almela M, Lowman W, Hsueh PR, Navarro-San Francisco C, Torre-Cisneros J, Carmeli Y, Bonomo RA, Paterson DL, Pascual Á, Rodríguez-Baño J, REIPI/ESGBIS/INCREMENT Group.

    Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-ß-lactamase-producing Enterobacteriaceae.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 72(3): 906-913. Nº de citas: 43

    [doi:10.1093/jac/dkw513]

  • Dominguez-Molina B, Tarancon-Diez L, Hua S, Abad-Molina C, Rodriguez-Gallego E, Machmach K, Vidal F, Tural C, Moreno S, Goñi JM, Ramírez de Arellano E, Del Val M, Gonzalez-Escribano MF, Del Romero J, Rodriguez C, Capa L, Viciana P, Alcamí J, Yu XG, Walker BD, M L, Lichterfeld M, Ruiz-Mateos E, ECRIS integrated in the Spanish AIDS Research Network.

    HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.

    CLINICAL INFECTIOUS DISEASES . 64(5): 621-628. Nº de citas: 23

    [doi:10.1093/cid/ciw833]

  • Morillo CA, Waskin H, Sosa-Estani S, Del Carmen Bangher M, Cuneo C, Milesi R, Mallagray M, Apt W, Beloscar J, Gascon J, Molina I, Echeverria LE, Colombo H, Perez-Molina JA, Wyss F, Meeks B, Bonilla LR, Gao P, Wei B, McCarthy M, Yusuf S, STOP-CHAGAS Investigators.

    Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.

    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY . 69(8): 939-947. Nº de citas: 172

    [doi:10.1016/j.jacc.2016.12.023]

  • Serrano-Villar S, Vásquez-Domínguez E, Pérez-Molina JA, Sainz T, de Benito A, Latorre A, Moya A, Gosalbes MJ, Moreno S.

    HIV, HPV, and microbiota: partners in crime?

    AIDS . 31(4): 591-594. Nº de citas: 18

    [doi:10.1097/QAD.0000000000001352]

  • Fortun J, Modi YS, Bessette A, Heffez J, Carvounis P, Petkovsek DS, Anderson NG, Martin D, Srivastava S.

    Clinical Features and Management of Subretinal Abscesses Secondary to Methicillin-Resistant Staphylococcus aureus Endogenous Endophthalmitis.

    OPHTHALMIC SURGERY LASERS & IMAGING RETINA . 48(2): 134-142. Nº de citas: 5

    [doi:10.3928/23258160-20170130-07]

  • Temkin E, Torre-Cisneros J, Beovic B, Benito N, Giannella M, Gilarranz R, Jeremiah C, Loeches B, Machuca I, Jiménez-Martín MJ, Martínez JA, Mora-Rillo M, Navas E, Osthoff M, Pozo JC, Ramos Ramos JC, Rodriguez M, Sánchez-García M, Viale P, Wolff M, Carmeli Y.

    Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms.

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . 61(2): . Nº de citas: 118

    [doi:10.1128/AAC.01964-16]

  • Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Crespo M, Domingo P, Estrada V, Iribarren JA, Knobel H, Lázaro P, López-Aldeguer J, Lozano F, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, de la Torre J, Tuset M, Gatell JM.

    Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 35(2): 88-99. Nº de citas: 5

    [doi:10.1016/j.eimc.2016.06.013]

  • Ponce-Alonso M, Del Campo R, Fortun J, Canton R, Morosini MI.

    First description of late recurrence of catheter-associated bacteraemia due to Cellulosimicrobium cellulans.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 35(2): 131-133. Nº de citas: 3

    [doi:10.1016/j.eimc.2016.05.003]

  • Gudiol C, Royo-Cebrecos C, Tebe C, Abdala E, Akova M, Álvarez R, Maestro-de la Calle G, Cano A, Cervera C, Clemente WT, Martín-Dávila P, Freifeld A, Gómez L, Gottlieb T, Gurguí M, Herrera F, Manzur A, Maschmeyer G, Meije Y, Montejo M, Peghin M, Rodríguez-Baño J, Ruiz-Camps I, Sukiennik TC, Carratalà J, BICAR study group.

    Clinical efficacy of ß-lactam/ß-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum ß-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR).

    BMJ open . 7(1): . Nº de citas: 8

    [doi:10.1136/bmjopen-2016-013268]

  • Neumayr A, Muñoz J, Schunk M, Bottieau E, Cramer J, Calleri G, López-Vélez R, Angheben A, Zoller T, Visser L, Serre-Delcor N, Genton B, Castelli F, Van Esbroeck M, Matteelli A, Rochat L, Sulleiro E, Kurth F, Gobbi F, Norman F, Torta I, Clerinx J, Poluda D, Martinez M, Calvo-Cano A, Sanchez-Seco MP, Wilder-Smith A, Hatz C, Franco L, for TropNet.

    Sentinel surveillance of imported dengue via travellers to Europe 2012 to 2014: TropNet data from the DengueTools Research Initiative.

    Eurosurveillance . 22(1): . Nº de citas: 23

    [doi:10.2807/1560-7917.ES.2017.22.1.30433]

  • Rueda C, Puig-Asensio M, Guinea J, Almirante B, Cuenca-Estrella M, Zaragoza O.

    Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia.

    CLINICAL MICROBIOLOGY AND INFECTION . 23(1): . Nº de citas: 30

    [doi:10.1016/j.cmi.2016.09.016]

  • Aldámiz-Echevarría Lois T, López-Polín A, Norman FF, Monge-Maillo B, López-Vélez R, Perez-Molina JA.

    Delayed haemolysis secondary to treatment of severe malaria with intravenous artesunate: Report on the experience of a referral centre for tropical infections in Spain.

    TRAVEL MEDICINE AND INFECTIOUS DISEASE . 15: 52-56. Nº de citas: 14

    [doi:10.1016/j.tmaid.2016.10.013]

  • Serrano-Villar S, Zhou Y, Rodgers AJ, Moreno S.

    Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 72(1): 235-239. Nº de citas: 23

    [doi:10.1093/jac/dkw375]

  • Perez-Molina JA, Rubio R, Rivero A, Pasquau J, Suárez-Lozano I, Riera M, Estébanez M, Palacios R, Sanz-Moreno J, Troya J, Mariño A, Antela A, Navarro J, Esteban H, Moreno S.

    Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study).

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 72(1): 246-253. Nº de citas: 51

    [doi:10.1093/jac/dkw379]